Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

By M. Romero‐Gomez, María del Mar Viloria, R. Andrade, J. Salmerón, M. Diago, C. Fernández-Rodríguez, R. Corpas, Marina Cruz, L. Grande, Luis Vázquez and 8 more. Gastroenterology, 2005

809 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/56bdee6434aa8e75cb625803421fa68f1fcb6d25

Citations in the corpus

• EASL Clinical Practice Guidelines: management of hepatitis C virus infection. (2011, background): “Insulin resistance is associated with fibrosis progression in chronic hepatitis C and an increased HOMA index has been shown to be an independent predictor of treatment failure in patients treated with pegylated IFN-a and ribavirin [116].”